Weight Loss & Nutrition Counseling
Our Medically Managed Weight Loss Program will help you reach your goals!
Eating right and exercising well may simply not be enough, especially as we age. We need a new tool to help us lose weight, and it is here! No special diets. No difficult workouts. JUST RESULTS!
Program Includes
-
Weight loss injections- Semaglutide or Tirzepatide
-
Nutrition Education - we are not dieticians we only provide guidance
-
Exercise Education
-
Accountability
Every 4-6 week Check ins
-
Weight tracking
-
Education to Help Reach Your Goals
Add Ons
-
B12 Injections
-
LIPO MIC injection (Super Skinny)
-
IV Infusions: Anti- Aging, Immune Booster, Wellness, Recovery
Semaglutide Weight Loss
It has been a long time, 2014 to be exact, since a new weight loss drug has hit the market, but help for individuals struggling to lose weight has finally arrived. The U.S. Food and Drug Administration (FDA) approved in June 2021 the use of semaglutide for weight loss.
Since its approval, thousands of people have seen amazing results with the use of this promising new weight loss drug and now it is your turn. Body Works, located in Franklin and Nolensville, Tennessee, offers a semaglutide program that is known for producing amazing weight loss results with minimal side effects.
Curious to see exactly how this new drug is changing how people approach weight management and if it might be right for you? Continue reading to learn more about semaglutide and how it is used as part of a weight loss and weight management program.
What is Semaglutide?
If semaglutide sounds familiar, that is because, before it was approved for use for long-term weight management, it was the active ingredient in medications used to treat Type 2 Diabetes. In 2017, Ozempic, an injectable medication with the main ingredient of semaglutide, was approved by the FDA for treatment of Type 2 Diabetes. It was followed in 2019 by the approval of Rybelus, an oral pill with the main ingredient of semaglutide for Type 2 Diabetes.
People began to notice that while Ozempic and Rybelus increased insulin production by stimulating the pancreas, which helped to lower blood sugar levels, it had another unexpected side effect – weight loss.
After conducting numerous clinical studies, the manufacturers of Ozempic and Rybelus, Novo Nordisk, created a new drug known as Wegovy which uses semaglutide for weight loss. In 2021, this revolutionary weight loss medication gained FDA approval and has since helped thousands of people lose weight.
Just how much weight have people lost with the use of semaglutide? Clinical studies showed that many people were able to lose 15% to 20% of their starting weight with the use of semaglutide.
How Does Semaglutide Work for Weight Loss?
Semaglutide is a glucagon-like peptide 1 agnostic. It is commonly known by its much shorter name of GLP-1 agonist. GLP-1 is a natural hormone that is produced by the gastrointestinal system to help with insulin production by stimulating the pancreas, but it can also help signal to the brain a feeling of fullness.
Semaglutide is designed to mimic the natural hormone of GLP-1. When it is consumed or injected, the body reacts to it as if it naturally produced the GLP-1.
Semaglutide for weight loss slows the emptying of the stomach by binding to the receptors that are located in the lining of the stomach. The slower emptying of the stomach sends a signal of fullness to the brain. This helps reduce your food intake and decreases your appetite, two things that are necessary for weight loss, because you feel full and are less likely to want to eat.
By combining insulin production, which encourages the body to break down foods and fats more efficiently, with the feeling of fullness that comes from the slower emptying of the stomach, you can see dramatic weight loss results with the use of semaglutide.
Tirzepatide
Obesity is the most common chronic medical disease. Rather than having a simple solution of eating less and moving more, treatment requires a comprehensive approach. The addition of the medication tirzepatide is a powerful tool in the treatment of obesity. Tirzepatide is one of a new class of medications called GLP-1/GIP receptor agonists. Tirzepatide is only FDA approved for diabetes, but its effect on weight is dramatic: 22% weight loss in the SURMOUNT-1 study. That’s 44 pounds in a 200 pound person!
This molecule reduces appetite in three ways:
-
It stimulates the GLP-1 receptors in the brain, resulting in feeling full and dramatically reducing appetite.
-
It stimulates the GIP receptor, which enhances the effect of GLP-1.
-
It slows emptying of the stomach, so food stays in the stomach longer, so there is less food available for the addition of new food.
Treatment of obesity treatment requires several combined therapies. Medication is one of them. In patients with diabetes type 2 and excess body weight, Tizepatide is an excellent option. Nutrition management accounts for 90% of weight loss, and weight loss medications make following the meal plan easier. Lifestyle education and support help people gain long term maintenance tools. Exercise is also critical to keeping off weight and is a small contributor to weight gain. By combining these tools, patient often get dramatic and sustained weight loss.
